| |
|
|
| Name: |
Octagon Capital Advisors LP |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10065 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
38 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
NUVB.WS |
Nuvation Equity Warrants Ex... |
1 |
- |
$0.00 |
$48,102,000 |
27,330,800 |
9.47% |
47,271,000 |
27,018,464 |
303.676 |
N/A |
|
|
APLS |
Apellis Pharmaceuticals Inc |
2 |
- |
$17.31 |
$45,796,000 |
2,094,000 |
9.01% |
-50,157,000 |
-912,980 |
1.689 |
N/A |
|
|
DNTH |
Dianthus Therapeutics Ord Shs |
3 |
- |
$0.70 |
$42,478,000 |
2,341,667 |
8.36% |
-3,524,000 |
231,500 |
7.205 |
N/A |
|
|
AVBP |
Arrivent Biopharma, Inc. |
4 |
- |
$21.77 |
$38,078,000 |
2,059,387 |
7.49% |
-16,784,000 |
0 |
6.149 |
N/A |
|
|
TRVI |
Trevi Therapeutics, Inc. |
5 |
New |
$0.00 |
$20,895,000 |
3,322,000 |
4.11% |
20,895,000 |
3,322,000 |
3.265 |
N/A |
|
|
CNTA |
Centessa Pharmaceuticals Plc |
6 |
- |
$0.00 |
$20,492,000 |
1,425,000 |
4.03% |
-12,892,000 |
-568,052 |
1.088 |
N/A |
|
|
GOSS |
Gossamer Bio Inc |
7 |
- |
$1.23 |
$20,185,000 |
18,350,000 |
3.97% |
3,586,000 |
0 |
8.141 |
N/A |
|
|
OCUL |
Ocular Therapeutix, Inc |
8 |
- |
$0.00 |
$17,775,000 |
2,425,000 |
3.5% |
-2,935,000 |
0 |
1.555 |
N/A |
|
|
MNMD |
Mind Medicine |
9 |
- |
$6.49 |
$17,655,000 |
3,018,000 |
3.47% |
-3,350,000 |
0 |
3.706 |
N/A |
|
|
COGT |
Cogent Biosciences, Inc. |
10 |
- |
$7.18 |
$16,550,000 |
2,763,000 |
3.26% |
-5,001,000 |
0 |
2.118 |
N/A |
|
|
KALV |
Kalvista Pharmaceuticals Inc |
11 |
- |
$11.31 |
$15,810,000 |
1,370,000 |
3.11% |
4,206,000 |
0 |
2.615 |
N/A |
|
|
TSHA |
Taysha Gene Therapies, Inc. |
12 |
- |
$0.00 |
$14,873,000 |
10,700,000 |
2.93% |
-3,206,000 |
250,000 |
5.723 |
N/A |
|
|
NUVB |
Nuvation Bio Ord Shs Class A |
13 |
- |
$10.42 |
$13,904,000 |
7,900,000 |
2.74% |
-10,576,000 |
-1,302,907 |
3.646 |
N/A |
|
|
VRNA |
Verona Pharma Plc |
14 |
- |
$0.00 |
$13,794,000 |
217,264 |
2.71% |
-12,736,000 |
-354,000 |
0.269 |
N/A |
|
|
TRML |
Tourmaline Bio |
15 |
New |
$0.00 |
$13,765,000 |
905,000 |
2.71% |
13,765,000 |
905,000 |
2.191 |
N/A |
|
|
MRUS |
Merus Nv |
16 |
- |
$52.60 |
$12,964,000 |
308,000 |
2.55% |
13,000 |
0 |
0.43 |
N/A |
|
|
PHVS |
Pharvaris N V Ord Shs |
17 |
- |
$0.00 |
$12,086,000 |
769,815 |
2.38% |
-2,828,000 |
-8,185 |
0.186 |
N/A |
|
|
MLTX |
Multisys Language Solutions... |
18 |
New |
$0.00 |
$11,565,000 |
296,000 |
2.28% |
11,565,000 |
296,000 |
0.471 |
N/A |
|
|
SNDX |
Syndax Pharmaceuticals Inc |
19 |
- |
$9.37 |
$11,106,000 |
904,000 |
2.19% |
-845,000 |
0 |
0.962 |
N/A |
|
|
LIFE |
aTyr Pharma Inc |
20 |
- |
$0.37 |
$10,727,000 |
3,552,000 |
2.11% |
7,469,000 |
2,652,000 |
6.066 |
N/A |
|
|
SRRK |
Scholar Rock Holding Corp |
21 |
- |
$35.42 |
$10,577,000 |
329,000 |
2.08% |
-10,514,000 |
-159,000 |
0.38 |
N/A |
|
|
VSTM |
Verastem, Inc. |
22 |
New |
$4.15 |
$10,372,000 |
1,720,000 |
2.04% |
10,372,000 |
1,720,000 |
3.822 |
Biotechnology |
|
|
RGLS |
Regulus Therapeutics Inc. |
23 |
- |
$8.16 |
$8,115,000 |
4,637,076 |
1.6% |
454,000 |
-211,726 |
3.176 |
Biotechnology |
|
|
SBTX |
Silverback Therapeutics, Inc. |
24 |
New |
$0.00 |
$7,863,000 |
625,000 |
1.55% |
7,863,000 |
625,000 |
0.361 |
N/A |
|
|
ABVX |
Abivax S.A |
25 |
New |
$7.65 |
$7,688,000 |
1,230,000 |
1.51% |
7,688,000 |
1,230,000 |
1.984 |
N/A |
|
|
ERAS |
Erasca, Inc. |
26 |
- |
$1.27 |
$7,037,000 |
5,136,795 |
1.38% |
-5,856,000 |
0 |
1.819 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
27 |
- |
$13.98 |
$6,066,000 |
450,000 |
1.19% |
-10,612,000 |
-420,000 |
0.5 |
N/A |
|
|
CRBP |
Corbus Pharmaceuticals Hold... |
28 |
- |
$6.90 |
$5,921,000 |
1,115,000 |
1.17% |
-7,236,000 |
0 |
0.89 |
N/A |
|
|
UNCY |
Unicycive Therapeutics, Inc. |
29 |
- |
$0.00 |
$5,749,000 |
10,000,000 |
1.13% |
-2,193,000 |
0 |
10.598 |
N/A |
|
|
MAZE |
Maze Therapeutics, Inc. |
30 |
New |
$12.27 |
$5,153,000 |
468,000 |
1.01% |
5,153,000 |
468,000 |
1.068 |
N/A |
|
|
CATX |
Perspective Therapeutics Inc |
31 |
- |
$3.44 |
$4,793,000 |
2,250,000 |
0.94% |
-2,559,000 |
-54,752 |
3.358 |
Medical Instruments &... |
|
|
KLRS |
Kalaris Therapeutics, Inc |
32 |
- |
$2.67 |
$3,862,000 |
481,000 |
0.76% |
-848,000 |
-10,734,000 |
0.78 |
N/A |
|
|
NGNE |
Neurogene |
33 |
- |
$3.68 |
$3,548,000 |
303,000 |
0.7% |
-3,379,000 |
0 |
0.723 |
N/A |
|
|
HLXB |
Helix Acquisition Corp. Ii |
34 |
- |
$10.62 |
$2,825,000 |
250,000 |
0.56% |
200,000 |
0 |
1.359 |
N/A |
|
|
BBIO |
Bridgebio Pharma, Inc. |
36 |
Closed |
$43.18 |
$0 |
0 |
0% |
-12,118,000 |
-441,600 |
0 |
N/A |
|
|
DYN |
Dyne Therapeutics, Inc. |
35 |
Closed |
$9.52 |
$0 |
0 |
0% |
-15,738,000 |
-668,000 |
0 |
N/A |
|
|
INSM |
Insmed Inc |
38 |
Closed |
$100.64 |
$0 |
0 |
0% |
-22,921,000 |
-332,000 |
0 |
Biotechnology |
|
|
MRSN |
Mersana Therapeutics, Inc. |
37 |
Closed |
$0.30 |
$0 |
0 |
0% |
-1,419,000 |
-992,000 |
0 |
N/A |
|
